In the present study, we noted that HBX-6 (100 mg/kg) and HBX-6 (200 mg/kg) reduced the expression of PCNA and PSA in testosterone-induced BPH mice (Figure 7). Here, KLK3 is linked to benign prostatic hyperplasia.